Skip to content

Alamar Biosciences ALMR Other Non-Current Assets

Other Non-Current Assets at other companies

Sherwin-Williams logo
Sherwin-WilliamsSHW
$1.78B+1.0%
Biogen logo
BiogenBIIB
$777.5M+39.1%
Emerson Electric logo
Emerson ElectricEMR
$2.88B+3.9%
Cigna logo
CignaCI
$3.25B+8.3%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$2.13B+52.9%
Omnicom Group logo
Omnicom GroupOMC
$744.4M+181%

Other financials

Income statement

See full
Revenue$26.0M+98.9%
Gross profit$14.5M+126%
Operating income-$12.3M-44.4%
Net income-$21.3M-178%
EPS (diluted)-$1.74-156%

Balance sheet

See full
Cash & equivalents$64.6M
Total debt$30.6M
Total equity-$178.1M
Total assets$186.5M

Cash flow

See full
Operating cash flow-$20.3M-55.7%
CapEx$600.0K+8.3%
Free cash flow-$20.9M-53.8%

Valuation

See full
Market cap$1.52B
Enterprise value$1.49B

Returns & leverage

See full
Debt / equity-0.2×
Current ratio5.9×

Where this comes from

Reported directly by Alamar Biosciences in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Alamar Biosciences ’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alamar Biosciences 's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alamar Biosciences 's other non-current assets?
Alamar Biosciences (ALMR) reported other non-current assets of $2.09M in Q1 2026.
What does other non-current assets mean?
This category captures long-term assets that do not fit into standard classifications like property, plant, equipment, or intangible assets. It may include long-term deposits, deferred tax assets, or other miscellaneous non-current investments. It represents the residual value of long-term resources held by the company.